A Comparative Study on Local Allergic Responses of Bee Venom and Essential Bee Venom Pharmacopuncture
Launched by JASENG HOSPITAL OF KOREAN MEDICINE · Feb 10, 2015
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
This double-blinded randomized clinical trial investigates difference in allergic responses elicited by Bee Venom (BV) and Essential Bee Venom (eBV). Twenty healthy volunteers aged 20-40 years were randomly allocated to the 2 groups and administered eBV and BV on left and right forearm, respectively, in accordance with group allocation. Physician, participant, and outcome assessor were blinded to group allocation. Local pain, swelling, itching, redness, wheals and adverse reactions were recorded by timepoint before and after treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with no prior exposure to bee venom treatment
- • Healthy individuals of both genders, 20 to 39 years old
- • Individuals able to communicate their thoughts
- • Voluntary participants who have provided written consent
- Exclusion Criteria:
- • Individuals on medications for chronic diseases (i.e. hypertension, hyperlipidemia)
- • Individuals with past history of allergic dermatitis
- • Individuals with past history of adverse events following bee stings
- • Individuals with symptoms of common cold
- • Individuals with fear of bee venom intervention or those who refuse to participate
About Jaseng Hospital Of Korean Medicine
Jaseng Hospital of Korean Medicine is a leading healthcare institution specializing in traditional Korean medicine and integrative health approaches. Committed to advancing clinical research and patient care, Jaseng focuses on evidence-based practices that combine traditional therapies with modern medical techniques. The hospital is dedicated to exploring innovative treatments through rigorous clinical trials, aiming to enhance therapeutic outcomes and improve the quality of life for patients. With a team of experienced practitioners and researchers, Jaseng Hospital plays a pivotal role in the global advancement of holistic healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, Gangnam Gu, Korea, Republic Of
Patients applied
Trial Officials
Joon-Shik SHIN, MD
Study Chair
Jaseng Hospital of Korean Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials